So sánh phương pháp

	Bảng câu hỏi về chất lượng cuộc sống trong Viêm mũi kết mạc dị ứng	Thang đo Khó thở, Ho và Đờm
Lĩnh vực	Hô hấp học	Hô hấp học
Họ	Process / pipeline	Process / pipeline
Năm ra đời	1996	2007
Người khởi xướng	Elizabeth F. Juniper, McMaster University	Multiple international authors (cardiopulmonary collaboration)
Loại	Self-report questionnaire	Self-report symptom scale
Công trình gốc	Juniper, E. F., Guyatt, G. H., Streiner, D. L., & King, D. R. (1996). Clinical validation and responsiveness of three scales developed to measure the effect of allergic rhinitis on quality of life. Journal of Clinical Epidemiology, 49(3), 339-347.	Rohrmann, S., Anker, S. D., Coats, A. J., Hildebrandt, P., & Köhler, F. (2007). Prognostic relevance of respiratory symptoms in patients with systolic left ventricular dysfunction. American Heart Journal, 153(1), 42-50.
Tên gọi khác	RQLQ, Rhinoconjunctivitis QoL	BCS, Breathlessness Cough Sputum
Liên quan	5	5
Tóm tắt	The RQLQ is a 28-item disease-specific quality-of-life instrument developed by Juniper and colleagues at McMaster University in 1996 to assess the impact of allergic rhinitis and allergic conjunctivitis on daily functioning. It captures symptom burden and activity limitation across seven domains: sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, activity limitation, and emotional function. The RQLQ is the preferred outcome measure in allergic rhinitis clinical trials and is widely used in allergy and immunology practice to track treatment response.	The BCS is a brief, symptom-focused assessment tool measuring the frequency and severity of three cardinal respiratory symptoms: breathlessness (dyspnea), cough, and sputum production. Developed in cardiopulmonary research as a pragmatic measure of disease burden in chronic heart failure and chronic obstructive pulmonary disease, the BCS provides rapid, patient-centered tracking of respiratory symptom trajectories. Unlike comprehensive quality-of-life questionnaires, the BCS concentrates solely on symptom phenotype, making it ideal for routine monitoring and longitudinal disease surveillance in busy clinical settings.